All Cosmos Bio-Tech Holding Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 911.96 million compared to TWD 565.51 million a year ago. Revenue was TWD 911.96 million compared to TWD 565.51 million a year ago. Net income was TWD 94.34 million compared to TWD 42.16 million a year ago. Basic earnings per share from continuing operations was TWD 1.47 compared to TWD 0.66 a year ago. Diluted earnings per share from continuing operations was TWD 1.47 compared to TWD 0.66 a year ago.
For the six months, sales was TWD 1,577.61 million compared to TWD 975.37 million a year ago. Revenue was TWD 1,577.61 million compared to TWD 975.37 million a year ago. Net income was TWD 162.84 million compared to TWD 69.28 million a year ago. Basic earnings per share from continuing operations was TWD 2.54 compared to TWD 1.08 a year ago. Diluted earnings per share from continuing operations was TWD 2.54 compared to TWD 1.08 a year ago.